CAS 899805-25-5

Tanzisertib

CAS: 899805-25-5

Tanzisertib (CC-930) (CC-930) is a potent inhibitor of JNK1/2/3 with IC50s of 61/7/6 nM, respectively, with potential antifibrotic activity.

Fórmula: C₂₁H₂₃F₃N₆O₂

Pureza: 98.66% - 99.28%

Forma y color: Solid

Peso molecular: 448.44

Ref: TM-T14895

CC 930

CAS: 899805-25-5

Fórmula: C₂₁H₂₃F₃N₆O₂

Pureza: 98%

Forma y color: Solid

Peso molecular: 448.4415

Ref: IN-DA00GU2C

CB30865

CAS: 899805-25-5

CB30865

Pureza: ≥98%

Peso molecular: 516.39g/mol

Ref: 54-BUP20579

Tanzisertib

CAS: 899805-25-5

Tanzisertib

Pureza: ≥98%

Peso molecular: 448.44g/mol

Ref: 54-BUP15237

Tanzisertib

CAS: 899805-25-5

Tanzisertib is a small molecule that is being studied for the treatment of cancer. It has been shown to inhibit the phosphorylation of c-jun and collagen, which are proteins that play an important role in the development of cardiac disease. Tanzisertib inhibits the binding of a number of protein inhibitors, such as erythropoietin receptor (EPOR), epidermal growth factor receptor (EGFR), and vascular endothelial growth factor receptor 2 (VEGFR2). This drug also has immunomodulatory effects, which may be due to its ability to inhibit the production of inflammatory cytokines. Tanzisertib has been shown to inhibit tumor cell proliferation by inhibiting protein synthesis and cell division, which may lead to tumor shrinkage.

Fórmula: C₂₁H₂₃F₃N₆O₂

Pureza: Min. 95%

Peso molecular: 448.44 g/mol

Ref: 3D-FT74805